DHA Supplements Market to Surpass US$ 2,237.9 Million by 2028 - Coherent Market Insights

Global DHA Supplements Market, by Source (Fish Oil, Algal Oil, Krill Oil, and Others), by Form (Liquid, Capsules, and Powder), by Application (Pharmaceutical, Dietary Supplements, Fortified Food and Beverages, and Others), by Distribution Channel (Pharmacy and Drug Stores, Grocery Stores, Dietary Supplement Stores, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,385.8 Million in 2021 and is expected to exhibit a CAGR of 7.0% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Increased adoption of inorganic strategies such as agreements and collaborations by the key players in the market is expected to drive growth of the global DHA supplements market over the forecast period. For instance, in September 2021, Solarvest BioEnergy Inc., a Canada-based algae biologics company, announced that its wholly-owned division, Eversea Inc., a biotechnology company, signed sales and promotional agreements with OrgHive, China’s leading digital marketing and e-commerce platform dedicated to organic consumers. As a part of this agreement, OrgHive will promote Eversea’s algae-based, certified organic omega-3 DHA in China and other parts of Asia.

Global DHA Supplements Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, supplements such as DHA has gained a lot of attention in the COVID-19 pandemic, owing to its influence on the immunological response to viral infections. For instance, according to an article published by Frontiers Media S.A., an open-access publisher of peer-reviewed scientific articles, in June 2020, the COVID-19 pandemic and subgroup of patient death was attributed to the so-called ‘cytokine storm’ phenomenon that is also called  cytokine release syndrome or macrophage overactivation syndrome. According to the same source, LC-PUFAs (long chain polyunsaturated fatty acids) such as EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) modulated the immune response and function in many ways. Both EPA and DHA can decrease the secretion of inflammatory cytokines and also reduce the triglyceride levels in the blood. Lower levels of triglyceride present a lower risk of developing a ‘cytokine storm’. This approach adds to the growing evidence supporting the use of n-3 LC-PUFA supplementation in COVID-19 illness. Thus, the COVID-19 pandemic brought a lot of attention to the use of DHA supplements in reducing the risk of infection, thereby prompting the researchers to research more about DHA supplements. The increasing research on DHA supplements in treating or reducing the risk of infections is expected to drive the global DHA supplements market growth over the forecast period.

Browse 27 Market Data Tables and 31 Figures spread through 156 Pages and in-depth TOC on “Global DHA Supplements Market”-  Forecast to 2028, Global DHA Supplements Market, by Source (Fish Oil, Algal Oil, Krill Oil, and Others), by Form (Liquid, Capsules, and Powder), by Application (Pharmaceutical, Dietary Supplements, Fortified Food and Beverages, and Others), by Distribution Channel (Pharmacy and Drug Stores, Grocery Stores, Dietary Supplement Stores, and Others),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/dha-supplements-market-4951

Moreover, increasing product launches are expected to drive the growth of the global DHA supplements market over the forecast period. For instance, in February 2021, Solarvest BioEnergy Inc., a Canada-based algae biologics company, announced the launch of the world's first organic Omega-3 Fruit Drop supplement containing DHA across the U.S. This organic omega-3 supplement is about 80% dried fruit, contains no added sugar, and contains the company’s patented and highly bioavailable organic Omega-3 DHA powder. 

Key Takeaways of the Global DHA Supplements Market:

• The global DHA supplements market is expected to exhibit a CAGR of 7.0% during the forecast period due to the increasing adoption of inorganic strategies by the key players in the market such as agreements, which is expected to boost growth of the market. For instance, in September 2021, AAK, a producer of vegetable oils and fats, announced a partnership with Progress Biotech, a company focusing on high quality biotech products for food, nutraceutical and pharma applications, to supply the algal oil DHA for infant formula.
• Among product types, the fish oil segment is estimated to hold a dominant position in the global DHA supplements market over the forecast period, owing to its increased use in dietary supplements and increasing product launches. For instance, in December 2018, Aeronutrix Sports Products Private Limited, a sports nutrition product company, launched Promega, an Omega-3-rich fatty acid fish oil.
• On the basis of applications, dietary supplements segment is estimated to account for the largest market share in the global DHA supplements market over the forecast period, due to the various health benefits provided by the DHA supplements intake. For instance, according to an article published by Medindia, a leading online provider of health information, in December 2020, increasing the dietary intake of EPA and DHA through the consumption of fish-oil supplements or fatty fish to reduce the incidence of many chronic diseases that involve inflammatory processes such as inflammatory bowel disease (IBD), cardiovascular diseases, cancer, and rheumatoid arthritis.
• Major players operating in the global DHA supplements market include BASF Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International Plc, Pharma Marine AS, Clover Corporation, Omega Protein Corporation, Kingdomway Nutrition, Inc., ECPlaza Network Inc., Bizen Chemical Co.LTD, Stepan Company, Novotech Nutraceuticals, Inc., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine